Quality of life evolution in the first year after VATS lung resection and SABR for early stage NSCLC: a single centre analysis

C. Pompili (Leeds, United Kingdom), K. Franks (Leeds, United Kingdom), Z. Rogers (Leeds, United Kingdom), M. Callister (Leeds, United Kingdom), J. Robson (Leeds, United Kingdom), A. Brunelli (Leeds, United Kingdom), P. Holch (Leeds, United Kingdom), W. Chia (Leeds, United Kingdom), K. Absolom (Leeds, United Kingdom), G. Velikova (Leeds, United Kingdom)

Source: Virtual Congress 2020 – Challenging issues in thoracic surgery
Session: Challenging issues in thoracic surgery
Session type: Oral Presentation
Number: 4091
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Pompili (Leeds, United Kingdom), K. Franks (Leeds, United Kingdom), Z. Rogers (Leeds, United Kingdom), M. Callister (Leeds, United Kingdom), J. Robson (Leeds, United Kingdom), A. Brunelli (Leeds, United Kingdom), P. Holch (Leeds, United Kingdom), W. Chia (Leeds, United Kingdom), K. Absolom (Leeds, United Kingdom), G. Velikova (Leeds, United Kingdom). Quality of life evolution in the first year after VATS lung resection and SABR for early stage NSCLC: a single centre analysis. 4091

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quality of life after lung resection due to malignant neoplasm in Brazilian patients
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


Quality of life assessment in advanced stage of lung cancer patients before and after chemotherapy
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Quality of life 3 months following lung cancer resection
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Sublobar resections vs lobectomy for early stage lung cancer: where do we stand?
Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process?
Year: 2020


The optimal treatment of stage I nonsmall cell lung cancer in the era of SABR and modern day lung resections
Source: Eur Respir J, 56 (5) 2002595; 10.1183/13993003.02595-2020
Year: 2020



Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Assessment of lung function and quality of life in patients submitted to lung resection for cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008

Cryotherapy plus chemotherapy or radiation offers increased survival and quality of life in advanced stage lung cancer patients with endobronchial obstruction: Analysis of 160 patients treated with the rigid bronchoscope
Source: Annual Congress 2012 - Mediastinum and tracheobronchial tree
Year: 2012

Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT).
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection
Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020
Year: 2020



Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018

Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients?
Source: Eur Respir J 2002; 19: 464-468
Year: 2002



A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015



Impact of early weight loss during concurrent chemoradiotherapy on survival in advanced stage NSCLC patients
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Long time survival after resection for multiple primary lung cancers. A population-based study
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018



Treatment of early (stage I/II) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


COPD and resectable bronchogenic carcinoma: worse quality of life after surgery?
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006

Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

A single centre review of palliative chemotherapy in newly diagnosed stage IIIb and IV lung cancer patients with good performance status
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013